Sunir Garg, Hawaiian Eye 2022: Mask Use and Endophthalmitis
Access all of the content
Universal mask use was shown to be effective at reducing incidence of endophthalmitis, according to results of a study presented at Hawaiian Eye 2022. We caught up with Dr Sunir Garg (Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA), who gave us an overview of his retrospective review on mask use and incidence of endophthalmitis.
The abstract entitled What Intravitreal Injections have Taught us about Endophthalmitis was presented at Hawaiian Eye 2022, 15–21 January 2022.
- Could you tell us a little about the retrospective review you are presenting? (00:15)
- What was the impact of universal mask use on the incidence of endophthalmitis? (02:40)
- How will these findings affect future clinical practice? (03:25)
Speaker Disclosure: Sunir Garg has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of Hawaiian Eye 2022.
Share this Video
Related Videos In Retina/Vitreous
Carl Regillo, Hawaiian Eye and Retina 2023: New and emerging treatments for neovascular age-related macular degeneration
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about new and emerging neovascular age-related macular degeneration treatments, including the new anti-vascular endothelial growth factor which appear to lead to better outcomes with durability, which is one of the biggest unmet needs in treatment of age-related macular […]
Carl Regillo, Hawaiian Eye and Retina 2023: Vascular endothelial growth factor inhibitors – real-world versus clinical trial outcomes
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about the problems with the clinical utility of vascular endothelial growth factor inhibitors and the issues around durability and ensuring good outcomes in real-world settings, as opposed to just in clinical trials. Questions: How do age-related macular degeneration […]
Roxane Hillier, EURETINA 2022: Mechanisms of action in rhegmatogenous retinal detachment repair (Part 1)
It was a pleasure to talk to Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) on her EURETINA course on rhegmatogenous retinal detachment repair. In this interview, she discussed the treatment options for rhegmatogenous retinal detachment. The instructional course entitled “Mechanisms of Action in Rhegmatogenous Retinal Detachment Repair” was conducted at EURETINA 2022, 1–4 September 2022 […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!